Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion type Assertion NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_head.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion description "[Synaptojanin-1 and C21orf2 were increased in DS, but others were comparable between DS and controls, suggesting that the DS phenotype cannot be simply explained by gene dosage effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion evidence source_evidence_literature NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion SIO_000772 12624744 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion wasDerivedFrom befree-20140225 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.
- NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_assertion wasGeneratedBy ECO_0000203 NP461897.RAdSVA5FKpS1w2l6eYZ7jX28clkMW1MEhMqnP_4QeVOcw130_provenance.